Showing 541 - 560 results of 30,886 for search '(( 50 ((mean decrease) OR (we decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 0.95s Refine Results
  1. 541
  2. 542
  3. 543

    Analysis of the <sup>1</sup>H-<sup>15</sup>N HSQC Spectra of mS100A4 in Complex with Amlexanox. by Ching Chang Cho (3080076)

    Published 2016
    “…(C) Ribbon representation of mS100A4, with residues that exhibited a decrease in cross-peak intensity mapped (red) on the ribbon diagram.…”
  4. 544
  5. 545
  6. 546
  7. 547

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis.…”
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554
  15. 555

    Serum and urinary Klotho, S100A8/A9, and neutrophil gelatinase-associated lipocalin (NGAL) concentrations in acute kidney injury patients. by Ae Jin Kim (610338)

    Published 2016
    “…(b) Urinary S100A8/A9/Cr was increased significantly in intrinsic AKI patients. …”
  16. 556

    Serum and urinary Klotho, S100A8/A9, and Neutrophil gelatinase-associated lipocalin (NGAL) concentrations in an acute kidney injury model. by Ae Jin Kim (610338)

    Published 2016
    “…(b) Serum and urinary S100A8/A9 and urinary S100A8/A9/Cr increased significantly in the cisplatin (CDDP) group. …”
  17. 557

    Semiquantitative immunoblotting and immunohistochemistry of the kidney from the acute kidney injury model. by Ae Jin Kim (610338)

    Published 2016
    “…(b) S100A8/A9 abundance was increased in the CDDP group (220%) versus the control (100%) and VD groups (83%). …”
  18. 558
  19. 559

    Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from <i>Gastrocnemius</i> Muscle by Guillaume Caron (816032)

    Published 2015
    “…Animals were divided in 2 experimental groups: 1) untreated animals acting as control and 2) treated animals in which the toxin was injected in the left muscle, the latter being itself divided into 3 subgroups according to their locomotor recovery with the help of a test based on footprint measurements of walking rats: i) no recovery (B0), ii) 50% recovery (B50) and iii) full recovery (B100). …”
  20. 560